Overview
To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.
Description
A prospective, phase II-III study, which will include a series of cases of 30 patients. The hospitals involved will be Bellvitge University Hospital and Hospital del Mar.
Efficacy was evaluated according magnetic resonance image and biopsy of the breast 1 month after the procedure.
Patients will be followed up over a 2-year period to assess cosmetic results, short and long-term complications and possible recurrences.
Eligibility
Inclusion Criteria:
- Infiltrating ductal carcinoma according the biopsy of the breast,
- Tumor visible by ultrasound, smaller than 2 cm,
- Located > 1 cm from the chest wall and the skin.
Exclusion Criteria:
- Personal antecedents of breast cancer
- Multifocality or intraductal carcinoma
- Lobular infiltrating carcinoma
- Neoadjuvant therapy